SynthesisClinical rheumatology2021

Efficacy and safety of tanezumab administered as a fixed dosing regimen in patients with knee or hip osteoarthritis: a meta-analysis of randomized controlled phase III trials.

Zheng-Rui Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.